Braun Stacey Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33M | Buy |
111,765
+7,560
| +7% | +$2.25M | 1.1% | 26 |
|
|
2025
Q4 | $28.5M | Buy |
104,205
+6,951
| +7% | +$1.89M | 0.92% | 34 |
|
|
2025
Q3 | $26.3M | Buy |
97,254
+7,336
| +8% | +$2M | 0.86% | 42 |
|
|
2025
Q2 | $24.8M | Buy |
+89,918
| New | +$24.5M | 0.9% | 43 |
|
|
2022
Q1 | – | Sell |
-5,475
| Closed | -$1.25M | – | 135 |
|
|
2021
Q4 | $1.25M | Sell |
5,475
-12,230
| -69% | -$2.69M | 0.05% | 115 |
|
|
2021
Q3 | $3.42M | Sell |
17,705
-11,554
| -39% | -$2.34M | 0.14% | 106 |
|
|
2021
Q2 | $6.22M | Sell |
29,259
-16,726
| -36% | -$3.53M | 0.24% | 104 |
|
|
2021
Q1 | $9.39M | Sell |
45,985
-21,655
| -32% | -$4.27M | 0.4% | 99 |
|
|
2020
Q4 | $12.3M | Sell |
67,640
-233
| -0.3% | -$39.6K | 0.55% | 88 |
|
|
2020
Q3 | $11.4M | Buy |
67,873
+1,817
| +3% | +$306K | 0.61% | 81 |
|
|
2020
Q2 | $10.7M | Buy |
66,056
+4,559
| +7% | +$817K | 0.62% | 81 |
|
|
2020
Q1 | $10.6M | Sell |
61,497
-2,185
| -3% | -$435K | 0.81% | 59 |
|
|
2019
Q4 | $12.8M | Sell |
63,682
-44,473
| -41% | -$9.12M | 0.71% | 82 |
|
|
2019
Q3 | $22.9M | Sell |
108,155
-1,590
| -1% | -$332K | 1.44% | 7 |
|
|
2019
Q2 | $21.3M | Sell |
109,745
-1,714
| -2% | -$316K | 1.36% | 10 |
|
|
2019
Q1 | $18.3M | Buy |
111,459
+406
| +0.4% | +$71.8K | 1.22% | 17 |
|
|
2018
Q4 | $20.9M | Sell |
111,053
-8,559
| -7% | -$1.58M | 1.66% | 5 |
|
|
2018
Q3 | $20.4M | Sell |
119,612
-1,298
| -1% | -$219K | 1.3% | 10 |
|
|
2018
Q2 | $19.8M | Sell |
120,910
-4,648
| -4% | -$759K | 1.35% | 12 |
|
|
2018
Q1 | $20.3M | Sell |
125,558
-4,810
| -4% | -$766K | 1.4% | 7 |
|
|
2017
Q4 | $19M | Sell |
130,368
-6,825
| -5% | -$972K | 1.28% | 16 |
|
|
2017
Q3 | $18.6M | Sell |
137,193
-10,760
| -7% | -$1.36M | 1.27% | 14 |
|
|
2017
Q2 | $18.5M | Sell |
147,953
-12,110
| -8% | -$1.45M | 1.2% | 20 |
|
|
2017
Q1 | $19M | Sell |
160,063
-13,315
| -8% | -$1.6M | 1.21% | 20 |
|
|
2016
Q4 | $20M | Sell |
173,378
-32,205
| -16% | -$3.58M | 1.31% | 7 |
|
|
2016
Q3 | $21.5M | Sell |
205,583
-2,355
| -1% | -$246K | 1.36% | 8 |
|
|
2016
Q2 | $20.3M | Buy |
207,938
+6,561
| +3% | +$620K | 1.31% | 9 |
|
|
2016
Q1 | $19.3M | Buy |
201,377
+22,299
| +12% | +$2.03M | 1.26% | 13 |
|
|
2015
Q4 | $16.2M | Sell |
179,078
-4,694
| -3% | -$442K | 1.02% | 47 |
|
|
2015
Q3 | $17M | Sell |
183,772
-4,155
| -2% | -$395K | 1.14% | 30 |
|
|
2015
Q2 | $17.5M | Buy |
187,927
+15,237
| +9% | +$1.42M | 0.74% | 63 |
|
|
2015
Q1 | $16.4M | Buy |
172,690
+77,630
| +82% | +$7.19M | 0.96% | 53 |
|
|
2014
Q4 | $8.43M | Buy |
+95,060
| New | +$8.06M | 0.51% | 89 |
|
|
2013
Q3 | – | Sell |
-5,150
| Closed | -$391K | – | 152 |
|
|
2013
Q2 | $391K | Buy |
+5,150
| New | +$338K | 0.02% | 124 |
|
Other funds holding CME
VCM
VPM
Braun Stacey Associates's CME Position: Q1 2026 in Review
Braun Stacey Associates increased its CME Group (CME) stake by 7.3% in Q1 2026, buying an estimated $2.25M and bringing the position to 111,765 shares worth $33M. The position accounts for 1.1% of the portfolio, ranked #26.
Braun Stacey Associates first reported a position in CME in Q2 2013 and has held it in 34 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Braun Stacey Associates held 111,765 shares of CME Group worth $33M as of Q1 2026.
- Braun Stacey Associates bought 7,560 CME Group shares in Q1 2026, an estimated $2.25M.
- CME Group made up 1.1% of Braun Stacey Associates's portfolio in Q1 2026, its #26 holding.
- Braun Stacey Associates first reported a position in CME Group in Q2 2013 and has held it in 34 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.